Featuring a slide presentation and related discussion from Dr Thomas Herzog, including the following topics:
- Keys to evaluating genetics in patients with ovarian cancer (0:00)
- Clinical trials evaluating PARP inhibitor maintenance therapy for patients with newly diagnosed ovarian cancer responding to platinum-based chemotherapy (7:35)
- Current status of PARP inhibitor use in the care of patients with ovarian cancer (18:45)
- Ongoing studies evaluating the combination of PARP and immune checkpoint inhibitors (24:37)
CME information and select publications
Research To Practice | Oncology Videos